Tatapower

Stay ahead with today’s top stock market updates! RBI has denied IREDA’s equity request for a Nepal project, while Gensol promoters sold 2.37% equity to reinvest in the business. Lupin launched Rivaroxaban tablets in the US, and Tata Power signed a ₹49,000 crore MoU for 7,000 MW renewable projects in Andhra Pradesh. Shilpa Medicare’s Raichur unit received a USFDA observation, and Shiv Nadar transferred 47% of his HCL Corp stake to Roshni Nadar Malhotra. Bodal Chemicals will benefit from new anti-dumping duties on imports from China and Japan. Stay tuned for more market insights!

Stocks to Watch: KPI Green, Tata Power, Adani Green, Airtel, coforge in focus on 27 February

Let's catch up on the latest news from the stock market. From significant investments to major deals, appointments, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:

Tata Power Q2 profit seen up 39% but revenue may fall 19%

Tata Power, one of the largest power generation companies in the private sector, is expected to report a 39 percent growth in profit at Rs 344 crore, according to average of estimates of analysts polled by CNBC-TV18.

Sensex, Nifty continue to rally; Cipla, NTPC laggards

Reliance, Tata Motors, HDFC Bank, BHEL and ICICI Bank are top gainers in the Sensex. Among the losers are Cipla, NTPC, Tata Power and Tata Steel.